Effect of anesthetic structure on inhalation anesthesia: Implications for the mechanism

Journal of Pharmaceutical Sciences

Volumn 97, Issue 6, 2008, Pages 2373-2384

  Abraham, Michael H ^a   Acree Jr , William E ^b   Mintz, Christina ^b   Payne, Stacy ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Hydrogen bond; Inhalation anesthesia; Minimum alveolar concentration; Molecular size; Multiple linear regression analysis; Two stage mechanism

Indexed keywords

ANESTHETIC AGENT; INHALATION ANESTHETIC AGENT;

ARTICLE; DRUG STRUCTURE; HYDROGEN BOND; INHALATION ANESTHESIA; MATHEMATICAL COMPUTING; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOLECULAR SIZE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; THEORY; THEORY OF NARCOSIS; ANIMAL; BIOLOGICAL MODEL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CONSCIOUSNESS; DOSE RESPONSE; DRUG EFFECT; PARTICLE SIZE; RAT; STRUCTURE ACTIVITY RELATION;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANIMALS; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN BONDING; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PARTICLE SIZE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 49249123726     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21150     Document Type: Article

References (63)

1. Liu J, Laster MJ, Taheri S. 1993. Is there a cutoff in potency for the normal alkanes? Anesth Analg 77:12-18.
2. Fang Z, Sonner J, Laster MJ, Ionescu P, Kandel L, Koblin DD, Eger EI II, Halsey MJ. 1996. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: Implications for mechanisms of narcosis. Anesth Analg 83:1097-1104.
3. Koblin DD, Chortkoff BS, Laster MJ, Eger EI II, Halsey MJ, Ionescu P. 1994. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 79:1043-1048.
4. Fang ZX, Ionescu P, Chortkoff BS, Kandel L, Sonner J, Laster MJ, Eger EI II. 1997. Anesthetic potenticies of n-alkanols: Results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 84:1042-1048.
5. Liu J, Laster MJ, Koblin DD, Eger EI II, Halsey MJ, Taheri S, Chortkoff B. 1994. A cut-off in potency exists in the perfluoroalkanes. Anesth Analg 79: 238-244.
6. Eger EI II, Halsey MJ, Harris RA, Koblin DD, Phhorille A, Sewell JC, Sonner JM, Trudell JR. 1999. Hypothesis: Volatile anesthetics produce immobility by acting on two sites approximately 5 carbon atoms apart. Anesth Analg 88:1395-1400.
7. Eger EI II, Laster MJ. 2001. The effect of rigidity, shape, unsaturation, and length on the anesthetic potency of hydrocarbons. Anesth Analg 92:1477-1482.
8. Taheri S, Halsey MJ, Liu J, Eger EI II, Koblin DD, Laster MJ. 1991. What solvent best represents the site of action of inhaled anesthetics in humans, rats and dogs? Anesth Analg 72:627-634.
9. Abraham MH. 1993. Scales of hydrogen bonding: Their construction and application to physicochem-ical and biochemical processes. Chem Soc Rev 22: 73-83.
10. Abraham MH, Ibrahim A, Zissimos AM. 2004. Determination of sets of solute descriptors from chromatographic measurements. J Chromatogr A 1037:29-47.
11. Won A, Oh I, Liao M, Sonner JM, Harris RA, Laster MJ, Brosnan R, Trudell JR, Eger EI II. 2006. The minimum alveolar anesthetic concentration of 2-, 3-, and 4-alcohols and ketones in rats: Relevance to anesthetic mechanisms. Anesth Analg 102:1419-1426.
12. Koblin DD, Laster MJ, Ionescu P, Gong D, Eger EI II, Halsey MJ, Hudlicky T. 1999. Polyhalogenated methyl ethyl ethers: Solubilities and anesthetic properties. Anesth Analg 88:1161-1167.
13. Taheri S, Laster MJ, Liu J, Eger EI II, Halsey MJ, Koblin DD. 1993. Anesthesia by n-alkanes not consistent with the Meyer-Overton hypothesis: Determinations of solubilities of alkanes in saline and various lipids. Anesth Analg 77:7-11.
14. Eger EI II, Ionescu P, Laster MJ, Gong D, Huklicky T, Kendig JJ, Harris A, Trudell JR, Pohorille A. 1999. Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: Relevance to theories of narcosis. Anesth Analg 88:867-876.
15. Zhang Y, Trudell JR, Mascia MP, Laster MJ, Gong DH, Harris RA, Eger EI II. 2000. The anesthetic potencies of alkanethiols for rats: Relevance to theories of narcosis. Anesth Analg 91:1294-1299.
16. Eger EI II, Liu J, Koblin DD, Laster MJ, Taheri S, Halsey MJ, Ionescu P, Chortkoff BS, Hudlicky T. 1994. Molecular properties of the "ideal" inhaled anesthetic: Studies of fluorinated methanes, ethanes, propanes and butanes. Anesth Analg 79: 245-251.
17. Eger EI II, Xing Y, Laster M, Sonner J, Antognini JF, Carstens E. 2003. Halothane and isoflurane have additive minimum alveolar concentration (MAC) effects in rats. Anesth Analg 96:1350-1353.
18. Eger EI II, Halsey MJ, Koblin DD, Laster MJ, Ionescu P, Konigsberger K, Fan R, Nguyen BV, Hudlicky T. 2001. The convulsant and anesthetic properties of cis-trans isomers of 1,2-dichlorohexa-fluorocyclo-butane and 1,2-dichloroethylene. Anesth Analg 93:922-927.
19. Koblin DD, Fang Z, Eger EI II, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR. 1998. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: Helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 87:419-424.
20. Gonsowski CT, Eger EI II. 1994. Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously expected. Anesth Analg 79:710-712.
21. Sewell JC, Halsey MJ. 1997. Shape similarity indices are the best predictors of substituted fluorethane and ether anaesthesia. Eur J Med Chem 32:731-737.
22. Won A, Oh I, Laster MJ, Popovich J, Eger EI II, Sonner JM. 2006. Chirality in anesthesia I: Minimum alveolar concentration of secondary alcohol enantiomers. Anesth Analg 103:81-84.
23. Zissimos AM, Abraham MH, Du CM, Valko K, Bevan C, Reynolds D, Wood J, Tarn KY. 2002. Calculation of Abraham descriptors from experimental data from seven HPLC systems: Evaluation of five different methods of calculation. J Chem Soc Perkin Trans 2:2001-2010.
24. Zissimos AM, Abraham MH, Barker MC, Box KJ, Tarn KY. 2002. Calculation of the Abraham descriptors for solvent-water partition coefficients in four different systems: Evaluation of different methods of calculation. J Chem Soc Perkin Trans 2:470-477.
25. Abraham MH, Gola JMR, Cometto-Muniz JE, Cain WS. 2001. Solvation properties of refrigerants, and the estimation of their water-solvent and gas-solvent partition coefficients. Fluid Phase Eq 180:41-58.
26. Davies RH, Bagnall RD, Jones WGM. 1974. A quantitative interpretation of phase effects in anaesthesia. Int J Quantum Biology Symp 1:201-212.
27. Davies RH, Bagnall RD, Bel W, Jones WGM. 1976. The hydrogen bond proton donor properties of volatile halogenated hydrocarbons and ethers and their mode of action in anaesthesia. Int J Quantum Biology Symp 3:171-185.
28. Overton E. 1901. Studien uber die Narkose. Jena: Fischer.
29. Meyer H. 1899. Zur theorie der alkoholnarkose: Erste mittheilung. Welche eigenschaft der anasthetika bedingt ihre narkotische wirking? Arch Exp Path Pharmak (Naunyn-Schmiedebergs) 42:109-118.
30. Meyer KH, Gottlieb-Bilroth H. 1920. Theorie der narkose durch inhalationsanasthetika. Zeit Physiol Chem 112:55-79.
31. Meyer KH, Hemmi H. 1935. Beitrage zur theorie der narkose. III. Biochem Z 277:39-71.
32. Abraham MH. 1996. The potency of gases and vapors: QSARs-anesthesia, sensory irritation and odor. In: Gammage RB, Berven BA, editors. Indoor air and human health. Boca Raton, FL: CRC Press. pp 67-89.
33. Abraham MH, Ibrahim A. 2006. Gas to olive oil partition coefficients: A linear free energy analysis. J Chem Inf Model 46:1735-1741.
34. Abraham MH, Chadha HS, Whiting GS, Mitchell RC. 1994. Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning, and the ΔlogP parameter of Seiler. J Pharm Sci 83:1085-1100.
35. Abraham MH, Whiting GS, Carr PW, Ouyang H. 1998. Hydrogen bonding. Part 45. The solubility of gases and vapours in methanol at 298K: An LFER analysis. J Chem Soc Perkin Trans 2:1385-1390.
36. Abraham MH, Whiting GS, Shuely WJ, Doherty RM. 1998. The solubility of gases and vapours in ethanol-the connection between gaseous solubility and water-solvent partition. Can J Chem 76: 703-709.
37. Abraham MH, Le J, Acree WE, Jr. 1999. The solvation properties of the aliphatic alcohols. Coll Czech Chem Comm 64:1748-1760.
38. Abraham MH, Le J, Acree WE, Jr., Carr PW, Dallas AJ. 2001. The solubility of gases and vapours in dry octan-1-ol at 298K. Chemosphere 44:855-863.
39. Abraham MH, Acree WE, Jr. 2006. Comparative analysis of solvation and selectivity in room temperature ionic liquids using the Abraham linear free energy relationship. Green Chem 6:906-915.
40. Abraham MH, Zissimos AM, Acree WE, Jr. 2003. Partition of solutes into wet and dry ethers; an LFER analysis. New J Chem 27:1041-1044.
41. Abraham MH, Platts JA, Hersey A, Leo AJ, Taft RW. 1999. Correlation and estimation of gas-chloroform and water-chloroform partition coefficients by a linear free energy relationship. J Pharm Sci 88: 670-679.
42. Abraham MH, Ibrahim A, Acree WE, Jr. 2007. Partition of compounds from gas to water and from gas to physiological saline at 310K; linear free energy relationships. Fluid Phase Eq 251:93-109.
43. Abraham MH, Ibrahim A, Acree WE, Jr. 2005. Air-to blood distribution of volatile organic compounds: A linear free energy analysis. Chem Res Toxicol 18:904-911.
44. Abraham MH, Ibrahim A, Acree WE, Jr. 2006. Air to brain, blood to brain and plasma to brain distribution of volatile organic compounds: Linear free energy analysis. Eur J Med Chem 41:494-502.
45. Abraham MH, Ibrahim A, Acree WE, Jr. 2006. Air to muscle and blood/plasma to muscle distribution of volatile organic compounds and drugs: Linear free energy analysis. Chem Res Toxicol 19:801-808.
46. Abraham MH, Ibrahim A. 2006. Air to fat and blood to fat distribution of volatile organic compounds and drugs: Linear free energy analyses. Eur J Med Chem 41:1430-1438.
47. Abraham MH, Ibrahim A, Acree WE, Jr. 2007. Air to liver partition coefficients for volatile organic compounds and blood to liver partition coefficients for volatile organic compounds and drugs. Eur J Med Chem 42:743-751.
48. Abraham MH, Ibrahim A, Acree WE, Jr. 2007. Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. Eur J Med Chem 42: in press.
49. Abraham MH, Ibrahim A, Acree WE, Jr. 2007. Air to kidney partition coefficients for volatile organic compounds and blood/plasma to kidney partition coefficients for volatile organic compounds and drugs. In preparation.
50. Abraham MH, Gola JRM, Cometto-Muňiz JE, Cain WS. 2001. The correlation and prediction of VOC thresholds for nasal pungency, eye irritation and odour in humans. Indoor Built Environ 10:252-257.
51. Abraham MH, Kumarsingh R, Cometto-Muňiz JE, Cain WS. 1998. Draize eye scores and eye irritation thresholds in man combined into one quantitative structure-activity relationship. Toxicol In Vitro 12:403-408, updated equation.
52. Abraham MH, Gola JRM, Cometto-Muňiz JE, Cain WS. 2002. A model for odour thresholds. Chem Senses 27:95-104.
53. Ishihama Y, Asakawa N. 1999. Characterization of lipophilicity scales using vectors from solvation energy descriptors. J Pharm Sci 88:1305-1312.
54. Abraham MH. 2003. Can we identify models for intestinal absorption, blood-brain barrier distribution and intestinal absorption? In: Ford M, Livingstone D, Dearden J, van de Waterbeemd H, editors. EuroQSAR 2002. Designing drugs and crop protectants: Processes, problems and solutions. Oxford: Blackwell. pp 5-7.
55. Abraham MH, Martins F. 2004. Human skin permeation and partition; general linear free-energy relationship analyses. J Pharm Sci 93:1508-1523.
56. Abraham MH, Nielsen GD, Alarie Y. 1994. The Ferguson principle and an analysis of the biological activity of gases. J Pharm Sci 83:680-688.
57. Abraham MH, Nasehzadeh A, Cook MJ, Kaberia F. 1980. Solvent effects on the cis and trans-4-t-butylcyclohexanol equilibrium by a new method, using gas-chromatographic head-space analysis. Chem Comm 312-313.
58. Abraham MH, Xodo LE, Cook MJ, Cruz R. 1982. Solvent and gas-phase effects on the equilibrium between configurational isomers of some 4-t- butylcyclohexanes. J Chem Soc Perkin Trans II:1503-1509.
59. Abraham MH, Andonian-Haftvan J, Whiting GS, Leo A, Taft RW. 1994. Hydrogen bonding, part 34: The factors that influence the solubility of gases and vapours in water at 298 K, and a new method for its determination. J Chem Soc Perkin Trans 2:1777-1791.
60. Abraham MH, Sanchez-Moreno R, Cometto-Muňiz JE, Cain WS. 2007. A quantitative structure-activity analysis on the relative sensitivity of the olfactory and the nasal trigeminal chemosensory systems. Chem Senses (in press).
61. Juza M, Braun E, Schurig V. 1997. Preparative enantiomeric separation of the inhalation anesthetics enflurane, isoflurane and desflurane by gas chromatography on a derivatized γ-cyclodextrin stationary phase. J Chromatogr A 769:119-127.
62. Sewell JC, Sear JW. 2004. Derivation of preliminary three-dimensional pharmacophores for nonha-logenated volatile anesthetics. Anesth Analg 99: 744-751.
63. Sewell JC, Sear JW. 2006. Determinants of volatile general anesthetic potency. A preliminary three-dimensional pharmacophore for halogenated anesthetics. Anesth Analg 102:764-771.